Abstract: E. coli heat stable enterotoxin STa is an agonist of the membrane guanylate cyclase C whose endogenous ligands are the peptide hormones guanylin and uroguanylin. Whereas these peptides contain only two disulfide bonds, STa is stabilized by one additional disulfide bridge. We chemically synthesized the enterotoxin STh that originates from the E. coli strain found in humans, and we determined its structure and its dynamics by nuclear magnetic resonance spectroscopy and molecular dynamics calculations. Chemical synthesis clearly proved successful and resulted in the formation of the native disulfide bonds. The endogenous ligands guanylin and uroguanylin show the same general structural features and dynamics properties as the enterotoxin.
INTRODUCTION
Many bacterial pathogens synthesize toxins that serve as virulence factors. Recently, these toxins became a topic of interest as a medication [1] [2] [3] , inactive toxin components (toxoids) were suggested to be used as as a vaccine [4] , toxins were used as tools to elucidate the complex events during signal transduction [5] , even as tumor markers and potential therapeutics in the treatment of colorectal and breast cancer [6] [7] [8] .
Enterotoxigenic E. coli bacteria (ETEC) produce two forms of heat-stable enterotoxins: STa (or STI) and STb (or STII) [9, 10] . These toxins cause acute and secretory diarrhea in humans, known as traveler's disease. In developing countries, this type of diarrhea is a major cause of death of infants [11] . STa consists of two subtypes that differ slightly in amino acid sequence and that are, for historic reasons, called STh (originally thought to occur in human E. coli strains only) and STp (originally thought to occur in porcine E. coli strains only).
STh is expressed as a precursor protein of 72 amino acids and it is cleaved twice before it is secreted as the mature 19 amino acid toxin [12] [13] [14] [15] . The toxic domain of STh is located in its carboxy-terminal region, between C6-C18, and it is highly conserved within the whole toxin family [5] . The 6 cysteins in this domain are arranged in three disulfide bridges, C6-C10, C7-C15 and C11-C18 [10] (Fig. 1) that are crucial for the peptide's toxicity [16, 17] . The same disulfide pattern and, generally, high sequence similarity is observed *Address correspondence to this author at the University of Bayreuth, Department of Biopolymers & Research Center for Bio-Macromolecules, D-95440 Bayreuth, Germany; E-mail: roesch@unibt.de in guanylin and uroguanylin (Fig. 1) , the endogenous peptide hormones that physiologically target the same receptor, membrane guanylate cyclase C, which is located at the brush border of the surface of cells of the intestine, and STh is able to displace both of these hormones from their receptor binding site [5, [18] [19] [20] [21] [22] . lar basis, and only a crystal structure (PDB: 1ETN, [25] ) and an NMR solution structure of STI are known [26] . We are currently examining the structural basis of STh recognition by GC-C, and, as an initial step, we determined the solution structure of the chemically synthesized STh (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) .
ENTEROTOXIN SYNTHESIS AND REFOLDING
The synthesis of STh (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) was performed using the Fmoc/But and maximal temporary protection strategy on a Syro II peptide synthesizer (MultiSynTech, Witten, Germany). The chemical procedure used 0.05 mmol of FmocTyr(tBu)-2-chlorotrityl resin, an eightfold excess of each amino acid (Fmoc Cys(Trt)-OH, Fmoc-Gly-OH, FmocThr(tBu)-OH, Fmoc-Ala-OH), Fmoc-Pro-OH, FmocAsn(Trt)-OH, Fmoc-Leu-OH and Fmoc-Glu(OtBu)-OH and 2-(1H-benzotriazole-1-yl)1,1,3,3-tetramethyluronium tetrafluoroborat/1-hydroxybenzotriazole (TBTU/HOBt) activation. Deprotection (2 h) and cleavage (100 mg peptide of resin) were achieved using 5 ml of a mixture of trifluoroacetic acid/thioanisole/ethandithiole (90/8/2, vol/vol/vol). The acidic mixture was then precipitated three times with diethylether, dissolved in 10 % aqueous acetic acid and freeze dried. The crude toxin was purified by RP-HPLC on a C18 semi-preparative column (10 x 150 mm; Nucleosil) using a 40-min gradient of acetonitrile in 0.055% trifluoroacetic acid (10-80% B in 40 min, where B is 80 % acetonitrile/H 2 O/0.05 % trifluoroacetic acid).
Oxidation of the reduced toxin was achieved by dissolving the purified peptide into 2 M acetic acid, and diluted to a peptide concentration of 0.015 mM in the presence of reduced/oxidized glutathione (molar ratio of peptide/GSH/GSSG was 1: 100: 10) and 2 M guanidine hydrochloride. The solution was adjusted to pH 8.0 with aqueous NH 4 OH and stirred slowly at 4 °C for 7 d. The folding reaction was monitored by analytical HPLC. The solution was concentrated using a C18 SepPak (Waters) cartridge and finally lyophilized. Initial purification of the oxidized product was achieved by chromatography on a C8 column using the system above and yielding a purity of ~ 90 %. Finally, the product was highly purified on a C18 column using a 60-min gradient, resulting in a purity of 95 %. The quality of the product was confirmed by analytical HPLC, matrix-assisted laser desorption/ionization time of flight mass spectrometry (MALDI-MS) giving the correct mass in excellent agreement of the oxidized product. 
NMR SPECTROSCOPY
Two-dimensional NMR spectra were recorded on Bruker DRX600 and AV800 spectrometers at 283 K with standard methods [27] . Standard 1 H-1 H correlated spectroscopy (COSY), 1 H-1 H total correlated spectroscopy (TOCSY) and 1 H-1 H homonuclear Overhauser enhancement spectroscopy (NOESY) were carried out with 4096x512 complex data points with excitation sculpting for water suppression [28] or coherence selection by pulsed field gradients [29] . Presaturation was applied for residual water suppression in experiments with the D 2 
STRUCTURE CALCULATIONS AND ANALYSIS
The total number of nontrivial unambiguous cross peaks in NOESY spectra was 190. The cross peaks were divided into three groups according to their relative intensities: strong with upper distance limit < 0.3 nm; medium, < 0.4 nm; and weak < 0.5 nm. Structure calculations were performed by using a modified ab initio SA protocol with the X-PLOR-NIH package [31] . The disulfide bonds were included explicitly. For each calculation 30 structures were calculated and 7 structures for each state were selected with the criteria for the lowest overall energy. Rasmol 2.7.3 [32, 33] and PyMol [34] were used for molecular presentation. The geometry of the structures was analyzed using PROCHECK-NMR [35] [36] [37] .
MD-SIMULATIONS
For further analysis and verification of our structural results we did an ab initio molecular dynamics simulation for STH and the hormones uroguanylin and guanylin [38] . The Amber 9 program package [39] and the ff03 force-field [40, 41] were used for the simulations of the three peptides. Each of them was constructed as an elongated peptide chain within the LEaP module of AMBER with the disulfide bonding as the only restraints.
The peptides were solvated in a TIP3P waterbox [42] with the dimensions of 80x60x40 Å, and for neutralization of the system sodium counterions were added. Calculations were performed at 286 K and an external pressure of 1 atm. At this conditions the systems were minimized and equilibrated using the program SANDER. Initially, the whole system was minimized for 1000 steps and the water molecules and the counterions were relaxed around the fixed solute with a 100-ps MD run. The systems were slowly heated stepwise to 286 K for equilibrating at each temperature. MD production runs of 2-ns duration were then performed for the systems. The MD data was analyzed by using the PTRAJ program. Root mean square deviation (r.m.s.d.) calculations of the heavy atoms were referenced to the NMR-structure of STH and the structures of the hormones deposited in the PDB (Guanylin: 1GUA, Uroguanylin; 1UYA), respectively.
RESULTS AND DISCUSSION
A detailed and well resolved solution structure of STh is needed for better understanding of processes that are involved into peptide recognition by its receptor. We thus chemically synthesized STh(6-19) and analyzed its NMR spectra. The chemical synthesis resulted in a peptide that was active in binding to the membrane proximal extracellular subdomain of human GCC with a nanomolar dissociation constant (Matecko et al., unpublished) .
The amide region of the proton NMR spectrum of STh showed the large dispersion of 2.5 ppm characteristic for a peptide with defined structure (Fig. 2) . Using standard through-bond and through-space 2D homonuclear and heteronuclear correlation experiments at natural abundance most of the resonances could be assigned (Table 1) , and only the amide proton of C7 and the resonances of C6 were not identified in the spectra. The severely increased linewidth of amide protons as well as the beta protons of residues C10, C11, L9 likely reflects conformational dynamics on the intermediate chemical shift time scale (μs-ms). The 13 C chemical shifts of cysteines are very sensitive to the oxidation state of the sulfur atom [43] . The C resonances of C10, C11, C15 and C18 are in the range between 36.9 -39.8 ppm. This characteristic down field shift indicates the oxidized state of these cysteines. The chemical shift of C7 (33.9 ppm) is in the intermediate region between upfield shifted resonances of reduced cysteines and downfield shifted resonances of oxided cysteines, the NOE cross peaks between C7-HA and C15-HB1,2 protons, however, clearly demonstrate the presence of the disulfide bond between these two residues. From this data it can be deduced that C6 must also be oxidized. Direct observation of the other two disulfide bonds by means of NOE cross peaks was not possible due to overlap with trivial intraresidual signals. The presence of the three disulfide bonds is also consistent with the observed molecular weight by mass spectroscopy (expected mass: 1475.46 Da, measured: 1475.43 Da). The NOESY cross peaks between P13 -protons and the -proton of N12 show the trans conformation of the proline. Slow solvent exchange of amide protons of C11, N12, and C15 (Fig. 2) suggests these residues to be Chemical shifts for Cys6, Sys7 could not be determined due to flexibility of amino terminus.
involved in hydrogen bonds. During the iterative structure determination hydrogen bonds between N12 CO and C15 H N ; C18 H N and C15 CO and C10 H N and C7 CO were deduced.
For the structure calculation 190 experimentally derived distance restrains were obtained. Due to the observed line broadening by conformational exchange NOE peak intensities were classified very conservatively to include effects of dynamical averaging. The ten accepted structures out of ten calculated superimpose with a backbone r.m.s.d. of 0.89 Å and show only low violations of experimental and geometrical restraints ( Table 2) . A PROCHECK-NMR analysis of STh shows that 51 % of the residues of the accepted structures are found in the most favoured regions and an additional 49 % in the allowed regions of the Ramachandran plot ( Table 2 ). The solution structure of STh (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) is composed of anhelical turn at its N-termius region and two -turns, between C11-C15, C15-C18 stabilised by the three disulfide bridges as mentioned before (Fig. 3) .
The unavailability of the coordinates of the solution conformation from Gariepy et al. [26] renders direct comparison of the structures impossible. Superimposing the present STh structure with the crystal structure (pdb code 1ETN [25] ), however, resulted in a backbone r.m.s.d. of 1.6 Å for residues C7-C18, mainly due to different orientation of the carboxy terminus. Restricting the fit to residues C7-G16 lowers the rmsd to 0.9 Å, demonstrating similar conformations in solution and in the crystal. The receptor binding region of STh and the endogenic GC-C pedptide ligands uroguanylin and guanylin is found to be from N12 -A14 for STh [44] and Y9 -A11 for guanylin [45] . In fact, these regions are highly solvent exposed for guanylin, uroguanylin, STp, and STh (Fig. 4) . Ab initio MD simulations with the NMR structures of guanylin, uroguanylin, and STh as starting structures show high flexibility of all three peptides in the loop regions ( Fig.   Fig. (4) . 5). The r.m.s.d. values of heavy atoms are in the same range for all three peptides, despite the additional disulfide bridge in STh. To evaluate the importance of the three disulfide bridges for the structure calculation of STh, we performed the identical calculations as we did for the NMR-structure determination, however, without taking into account the disulfide bridges. The energetically most favourable 15 structures were virtually the same as from the calculation containing both, the NOE restraints and the disulfide bridges. The largest difference in the structures was in the N-terminal loop and the carboxy-terminus of the peptide which both were observed to show higher flexibility. Fig. (5) . RMSD of the heavy atoms during the MD. Sth (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) referenced to the present structure (black); Uroguanylin referenced to PDB: 1UYA (light grey); Guanylin referenced to PDB: 1GNA (dark grey).
In addition to differences in structure and dynamics, STh may act as a toxin because it does not contain the chymotrypsin cleavage site found in guanylin, the endogenous peptide that predominantly acts in the large intestine, as opposed to uroguanylin [45] . Chymotrypsin is an enzyme of the intestinal tract, and it cleaves after aromatic amino acids such as Y9 of guanylin (Fig. 1) . In fact, the Y9NA10P double mutant of guanylin causes diarrhoea in suckling mice at much lower concentrations than the native peptide does [45] . Thus, one reason for the only transient action of native guanylin in the large intestine could be its rapid loss of its structure by enzymatic digestion.
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